Drug comparisons
Insulin Regular Human vs Lixisenatide
Regular insulin vs lixisenatide: short-acting mealtime vs once-daily GLP-1 agonist. Compare uses, frequency, weight and hypoglycemia in type 2 diabetes.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when type 2 diabetes patients evaluate adding mealtime insulin versus a GLP-1 agonist for glycemic control with fewer injections or weight benefits.
Bottom line
Regular human insulin and lixisenatide address different needs in diabetes care and are not direct substitutes.
All medication comparisons